Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Arooj Khan

Cardiovascular Disease Cleveland, OH Medical Doctor

NPI 1811421738 CMS profile 9178932

9500 Euclid Ave, Cleveland, OH 44195

Open in the dashboard

General payments

$36,735

98 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Arooj Khan of Cleveland, OH is reported in the CMS Open Payments database as having received $36,735 across 98 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Cardiovascular Disease profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $6,741 59
2024 General $21,106 15
2023 General $8,027 9
2022 General $600 9
2021 General $261 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Arooj Khan
  • Cardiovascular Disease median
  • Middle half of Cardiovascular Disease
  • National median

In program year 2025, general payments to Arooj Khan were reported at $6,741. Among 16,617 Cardiovascular Disease profiles paid that year, the median was $432 and the middle half received between $132 and $1,252.

Show as a table
Year Arooj Khan Cardiovascular Disease median Middle half National median
2019 $0 $450 $127–$1,392 $163
2020 $0 $242 $77–$751 $114
2021 $261 $335 $101–$1,037 $132
2022 $600 $395 $121–$1,211 $149
2023 $8,027 $443 $136–$1,283 $160
2024 $21,106 $450 $136–$1,323 $164
2025 $6,741 $432 $132–$1,252 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Abbott Laboratories $27,078 39 payments
  2. Boston Scientific Corporation $6,014 16 payments
  3. Medtronic, Inc. $3,015 26 payments
  4. Sanofi-Aventis U.S. LLC $247 4 payments
  5. Maquet Cardiovascular U.S. Sales, L.L.C. $104 2 payments
  6. Philips Electronics North America Corporation $59 1 payment
  7. Biosense Webster, Inc. $55 1 payment
  8. Abiomed $46 2 payments
  9. Biotronik Inc. $43 3 payments
  10. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $38 2 payments
  11. Other $38 2 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Grant $27,500 6 payments
  2. Food and Beverage $4,284 65 payments
  3. Travel and Lodging $3,872 17 payments
  4. Education $1,080 10 payments
Products named General payments · program years 2021–2025
  1. Micra $2,687 21 payments
  2. ENSITE Structural Heart $2,208 23 payments
  3. GALLANT $1,214 2 payments
  4. General - Therapies $309 5 payments
  5. ENSITE Electrophysiology $225 2 payments
  6. ENSITE PRECISION $179 1 payment
  7. AGILIS $162 1 payment
  8. RESONATE EL ICD VR $155 1 payment
  9. THORATEC HEARTMATE 3 LVAS IMPLANT KIT $153 1 payment
  10. WATCHMAN FLX $147 2 payments
  11. Other $1,253 32 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

98 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Cardiovascular Disease in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record